Role of bone scintigraphy (bone scan) in skeletal osteosarcoma: A retrospective audit and review from tertiary oncology centre

Ritesh Suthar; Nandlal Bharwani; Pravin Pareek; Abhijeet Ashok Salunke; Keval Patel; Shivang Shukla; Jebin Aron; Kanika Kapoor; Poojitha Yalla; Priyank Rathod; Shivam Pandya; Shashank Pandya

doi:10.1016/j.jor.2023.11.038

Role of bone scintigraphy (bone scan) in skeletal osteosarcoma: A retrospective audit and review from tertiary oncology centre

J Orthop. 2023 Nov 17:48:20-24. doi: 10.1016/j.jor.2023.11.038. eCollection 2024 Feb.

Authors

Ritesh Suthar¹, Nandlal Bharwani^{2

3}, Pravin Pareek¹, Abhijeet Ashok Salunke^{2

3}, Keval Patel³, Shivang Shukla³, Jebin Aron³, Kanika Kapoor³, Poojitha Yalla³, Priyank Rathod³, Shivam Pandya³, Shashank Pandya^{3

4}

Affiliations

¹ Nuclear Medicine, Gujarat Cancer Research Institute(GCRI), Ahemdabad, Gujarat, India.
² Orthopedic Oncology, Gujarat Cancer Research Institute (GCRI), Ahemdabad, Gujarat, India.
³ Surgical Oncology, Gujarat Cancer Research Institute (GCRI), Ahemdabad, Gujarat, India.
⁴ Gujarat Cancer Research Institute (GCRI), Ahemdabad, Gujarat, India.

PMID: 38059218
PMCID: PMC10696193 (available on 2025-02-01)
DOI: 10.1016/j.jor.2023.11.038

Abstract

Introduction: Bone scan is a investigation which uses radionuclide phosphonate compound for whole skeletal survey. In this current study we have done the analysis of the role of bone scan in skeletal osteosarcoma at tertiary oncology care centre.

Material & methods: This is a retrospective study conducted in a tertiary oncology centre from January 2022 to February 2023. A total of 92 patients with skeletal OGS were included in our study undergone 99 mTCcMDP whole body bone scan. 99 mTc MDP was prepared freshly every morning and dose for each patient were calculated as per EANM guidelines. Images were acquired 2-3 h of post injection. All images were acquired at GE infinia dual head machine with peak setting at 140Kev and LEAP collimator. Suspicious lesions on planer bone scan were correlated with SPECT fused with CT. All the bone scans were reviewed retrospectively by two independent nuclear medicine physicians.

Results: In this study group, 86 patients with biopsy proven skeletal OGS underwent 99 mTCcMDP bone scan of which 63 were males and 23 were females (2.7:1) with age of study group ranging from 7years to 48years. Patients referred for bone scan were retrospectively categorized in two groups, first group patients (52) were referred for initial staging of disease and second group of patients (34) were referred for follow-up or re-staging of the disease. Total 09 patients showed distant skeletal metastases on bone scan, out of which 05 were in initial staging group and 04 in follow up group.

Conclusion: Osteosarcoma has propensity to metastasize to many sites in the body however most common site being lung followed by skeletal, nodal and rarely soft tissue metastasis. Bone scan enjoys a optimal sensitivity in case of osteosarcoma to detect skeletal metastasis but have low specificity. However being a cost effective and faster investigation makes it a wise investigation of choice in case of osteosarcoma for skeletal metastasis evaluation.

Keywords: Bone scan; Bone scintigraphy; Oncology; Osteogenic sarcoma; Osteosarcoma.